Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
LAKE Lakeland Industries	$14.49 -1.0%	$14.56	$12.76 ▼ $27.28	$138.68M	1.11	128,698 shs	143,295 shs
LNSR LENSAR	$12.34 -1.0%	$12.74	$3.80 ▼ $17.31	$147.34M	0.49	124,180 shs	21,117 shs
LUCD Lucid Diagnostics	$1.06 +2.9%	$1.11	$0.73 ▼ $1.80	$114.99M	1.24	1.06 million shs	1.22 million shs
MYO Myomo	$0.88 +4.2%	$1.54	$0.81 ▼ $7.17	$33.24M	1.43	731,702 shs	2.89 million shs

10 Best Stocks to Own: Fall 2025

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
LAKE Lakeland Industries	0.00%	-2.34%	-2.27%	+6.32%	-28.74%
LNSR LENSAR	0.00%	+2.47%	-1.42%	+2.05%	+146.44%
LUCD Lucid Diagnostics	0.00%	-24.82%	+0.98%	-18.25%	+21.72%
MYO Myomo	0.00%	-15.42%	-13.45%	-69.75%	-83.86%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
LAKE Lakeland Industries	$14.49 -1.0%	$14.56	$12.76 ▼ $27.28	$138.68M	1.11	128,698 shs	143,295 shs
LNSR LENSAR	$12.34 -1.0%	$12.74	$3.80 ▼ $17.31	$147.34M	0.49	124,180 shs	21,117 shs
LUCD Lucid Diagnostics	$1.06 +2.9%	$1.11	$0.73 ▼ $1.80	$114.99M	1.24	1.06 million shs	1.22 million shs
MYO Myomo	$0.88 +4.2%	$1.54	$0.81 ▼ $7.17	$33.24M	1.43	731,702 shs	2.89 million shs

10 Best Stocks to Own: Fall 2025

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
LAKE Lakeland Industries	0.00%	-2.34%	-2.27%	+6.32%	-28.74%
LNSR LENSAR	0.00%	+2.47%	-1.42%	+2.05%	+146.44%
LUCD Lucid Diagnostics	0.00%	-24.82%	+0.98%	-18.25%	+21.72%
MYO Myomo	0.00%	-15.42%	-13.45%	-69.75%	-83.86%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
LAKE Lakeland Industries	2.75	Moderate Buy	$25.00	72.53% Upside
LNSR LENSAR	2.00	Hold	$15.00	21.56% Upside
LUCD Lucid Diagnostics	3.00	Buy	$3.65	244.34% Upside
MYO Myomo	3.00	Buy	$8.17	828.77% Upside

Current Analyst Ratings Breakdown

Latest MYO, LNSR, LAKE, and LUCD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/11/2025	LAKE Lakeland Industries	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$23.00 ➝ $20.00
9/5/2025	LUCD Lucid Diagnostics	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$2.00 ➝ $2.50
8/14/2025	LAKE Lakeland Industries	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/13/2025	LUCD Lucid Diagnostics	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$3.00
8/12/2025	MYO Myomo	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$9.50 ➝ $5.00
7/16/2025	LUCD Lucid Diagnostics	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$3.00
6/26/2025	MYO Myomo	Alliance Global Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
6/23/2025	MYO Myomo	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Buy	$10.00 ➝ $8.00

(Data available from 9/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
LAKE Lakeland Industries	$177.65M	0.78	$1.06 per share	13.71	$15.44 per share	0.94
LNSR LENSAR	$53.49M	2.75	N/A	N/A	$0.42 per share	29.38
LUCD Lucid Diagnostics	$4.35M	26.43	N/A	N/A	($0.78) per share	-1.36
MYO Myomo	$32.55M	1.02	N/A	N/A	$0.82 per share	1.07

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
LAKE Lakeland Industries	-$18.08M	-$2.74	N/A	8.73	N/A	-11.22%	-3.07%	-2.01%	12/4/2025 (Estimated)
LNSR LENSAR	-$31.40M	-$4.21	N/A	∞	N/A	-84.49%	-737.30%	-72.60%	11/6/2025 (Estimated)
LUCD Lucid Diagnostics	-$45.53M	-$1.19	N/A	N/A	N/A	-1,476.35%	N/A	-120.43%	11/12/2025 (Estimated)
MYO Myomo	-$6.18M	-$0.23	N/A	N/A	N/A	-22.87%	-50.87%	-27.00%	11/5/2025 (Estimated)

Latest MYO, LNSR, LAKE, and LUCD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
9/9/2025	Q2 2026	LAKE Lakeland Industries	-$0.04	$0.36	+$0.40	$0.08	$54.59 million	$52.50 million
8/7/2025	Q2 2025	LNSR LENSAR	-$0.0750	-$0.15	-$0.0750	-$0.15	$16.55 million	$11.36 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
LAKE Lakeland Industries	$0.12	0.83%	N/A	N/A	1 Years
LNSR LENSAR	N/A	N/A	N/A	N/A	N/A
LUCD Lucid Diagnostics	N/A	N/A	N/A	N/A	N/A
MYO Myomo	N/A	N/A	N/A	N/A	N/A

Latest MYO, LNSR, LAKE, and LUCD Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/1/2025	LAKE Lakeland Industries	quarterly	$0.03	0.9%	8/15/2025	8/15/2025	8/22/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
LAKE Lakeland Industries	0.19	3.66	1.41
LNSR LENSAR	N/A	1.52	0.88
LUCD Lucid Diagnostics	N/A	1.15	1.13
MYO Myomo	0.08	2.39	2.03

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
LAKE Lakeland Industries	71.69%
LNSR LENSAR	40.15%
LUCD Lucid Diagnostics	74.01%
MYO Myomo	44.99%

Insider Ownership

Company	Insider Ownership
LAKE Lakeland Industries	1.91%
LNSR LENSAR	66.00%
LUCD Lucid Diagnostics	6.80%
MYO Myomo	4.54%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
LAKE Lakeland Industries	2,100	9.57 million	9.39 million	Optionable
LNSR LENSAR	110	11.94 million	4.06 million	Optionable
LUCD Lucid Diagnostics	70	108.48 million	101.10 million	No Data
MYO Myomo	90	37.80 million	36.09 million	Not Optionable

MYO, LNSR, LAKE, and LUCD Headlines

Recent News About These Companies

Myomo to Present at the H.C. Wainwright 27th Annual Global Investment Conference

September 2, 2025 | businesswire.com

Myomo Inc. Earnings Call: Growth Amid Challenges

August 31, 2025 | tipranks.com

Myomo (NYSEAMERICAN:MYO) Director Thomas Kirk Purchases 50,000 Shares

August 27, 2025 | insidertrades.com

Myomo (NYSEAMERICAN:MYO) Director Thomas Kirk Acquires 50,000 Shares of Stock

August 20, 2025 | insidertrades.com

Insider Buying: Thomas Kirk Acquires 50,000 Shares of Myomo Inc (MYO)

August 19, 2025 | gurufocus.com

Myomo, Inc. (NYSEAMERICAN:MYO) CEO Paul R. Gudonis Acquires 50,000 Shares

August 19, 2025 | insidertrades.com

Rosalind Advisors, Inc. Increases Stake in Myomo Inc.

August 15, 2025 | gurufocus.com

MYO Earnings: Guidance Cut Slams Myomo Stock

August 12, 2025 | msn.com

Myomo Inc (MYO) Q2 2025 Earnings Call Highlights: Revenue Surge Amid Rising Costs and Strategic ...

August 12, 2025 | finance.yahoo.com

Why Medical Device Maker Myomo’s Stock Crashed 42% In After-Hours Trading

August 12, 2025 | msn.com

Myomo, Inc. Reports Q2 2025 Financial Results

August 11, 2025 | tipranks.com

Myomo, Inc. (MYO) Q2 2025 Earnings Conference Call Transcript

August 11, 2025 | seekingalpha.com

Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates

August 11, 2025 | zacks.com

Myomo outlines revised 2025 revenue growth target of 23%-29% as lead quality and pipeline conversion shift

August 11, 2025 | msn.com

Myomo Reports Second Quarter 2025 Financial and Operating Results

August 11, 2025 | businesswire.com

Myomo Q2 2025 Earnings Preview

August 11, 2025 | msn.com

Earnings To Watch: Myomo Inc (MYO) Reports Q2 2025 Result

August 10, 2025 | finance.yahoo.com

Insights Ahead: Myomo's Quarterly Earnings

August 9, 2025 | benzinga.com

Myomo to Report Second Quarter 2025 Financial Results on August 11

August 4, 2025 | businesswire.com

Myomo Reveals its $100 Revenue Goal During Investor Day

July 10, 2025 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

MYO, LNSR, LAKE, and LUCD Company Descriptions

Lakeland Industries NASDAQ:LAKE

$14.49 -0.14 (-0.96%)

Closing price 04:00 PM Eastern

Extended Trading

$14.34 -0.15 (-1.07%)

As of 05:14 PM Eastern

Lakeland Industries, Inc. manufactures and sells industrial protective clothing and accessories for the industrial and public protective clothing market worldwide. It offers firefighting and heat protective apparel to protect against fire; high-end chemical protective suits to provide protection from highly concentrated, toxic and/or lethal chemicals, and biological toxins; and limited use/disposable protective clothing, such as coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps, and smocks. The company provides durable woven garments, including electrostatic dissipative apparel used in electronics clean rooms; flame resistant meta aramid, para aramid, and FR cotton coveralls/pants/jackets used in petrochemical, refining operations, and electrical utilities; FR fabrics; and cotton and polycotton coveralls, lab coats, pants, and shirts. In addition, it provides high visibility clothing comprising reflective apparel, including vests, T-shirts, sweatshirts, jackets, coats, raingear, jumpsuits, hats, and gloves; and gloves and sleeves that are used in the automotive, glass, and metal fabrication industries. The company sells its products to a network of safety and industrial supply distributors through in-house sales teams, customer service group, and independent sales representatives. It serves end users, such as integrated oil, chemical/petrochemical, automobile, steel, glass, construction, smelting, cleanroom, janitorial, pharmaceutical, and high technology electronics manufacturers, as well as scientific, medical laboratories, and the utilities industry; and federal, state, and local governmental agencies and departments. Lakeland Industries, Inc. was incorporated in 1982 and is headquartered in Huntsville, Alabama.

LENSAR NASDAQ:LNSR

$12.34 -0.13 (-1.04%)

Closing price 04:00 PM Eastern

Extended Trading

$12.34 0.00 (0.00%)

As of 04:11 PM Eastern

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Lucid Diagnostics NASDAQ:LUCD

$1.06 +0.03 (+2.91%)

Closing price 04:00 PM Eastern

Extended Trading

$1.06 +0.00 (+0.47%)

As of 06:05 PM Eastern

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.

Myomo NYSEAMERICAN:MYO

$0.88 +0.04 (+4.19%)

Closing price 04:10 PM Eastern

Extended Trading

$0.87 -0.01 (-0.83%)

As of 05:46 PM Eastern

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MYO, LNSR, LAKE, and LUCD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MYO, LNSR, LAKE, and LUCD Earnings

Compare Dividends

Latest MYO, LNSR, LAKE, and LUCD Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MYO, LNSR, LAKE, and LUCD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

MYO, LNSR, LAKE, and LUCD Company Descriptions

Lakeland Industries NASDAQ:LAKE

LENSAR NASDAQ:LNSR

Lucid Diagnostics NASDAQ:LUCD

Myomo NYSEAMERICAN:MYO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools